Hantech Bio-Technology Co., Ltd. (TPEX:1294)

Hantech Bio-Technology Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	264.05	249.4	382.42	167.09	75.04	86.41
Trading Asset Securities	89.99	89.99	-	-	-	-
Cash & Short-Term Investments	374.05	339.38	382.42	167.09	75.04	86.41
Cash Growth	-13.23%	-11.25%	128.87%	122.67%	-13.16%	5.66%
Accounts Receivable	137.14	133.93	80.56	88.43	50.06	24.94
Other Receivables	3.1	1.59	0.21	0.21	0.01	0.01
Receivables	140.24	135.51	80.76	88.64	50.07	24.95
Inventory	111.41	112.06	70.34	80.47	29.32	22.04
Prepaid Expenses	4	1.35	1.11	3.72	4.24	1.78
Other Current Assets	3.23	3.23	-	-	-	-
Total Current Assets	632.92	591.53	534.63	339.91	158.68	135.17
Property, Plant & Equipment	568.19	558.71	566.87	551.32	285.23	227.04
Other Intangible Assets	3.59	3.95	5.96	3.25	1.47	1.2
Long-Term Deferred Tax Assets	2.56	2.61	1.79	1.81	2.27	1.06
Other Long-Term Assets	18.59	9.53	9.75	34.65	25.95	11.17
Total Assets	1,227	1,166	1,119	930.94	473.59	375.65

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	100.73	115.69	46.33	99.17	33.7	13.67
Accrued Expenses	-	63.66	43.56	49.75	25.29	25.4
Short-Term Debt	-	-	-	-	1	4
Current Portion of Long-Term Debt	15.25	24.37	51.22	23.18	5.94	5.06
Current Portion of Leases	8.08	5.75	6.26	6.63	6.57	6.78
Current Income Taxes Payable	19.98	16.48	21.73	30.01	8.91	0.97
Current Unearned Revenue	0.1	16.88	13.25	10.38	13.51	10.24
Other Current Liabilities	172.12	3.64	9.86	5.22	1.82	1.21
Total Current Liabilities	316.25	246.47	192.21	224.34	96.74	67.35
Long-Term Debt	62.2	69.3	92.25	285.1	84.48	110.37
Long-Term Leases	21.87	13.86	9.1	15.35	20.84	18.53
Long-Term Unearned Revenue	4.41	4.46	4.57	4.77	2.95	1.49
Long-Term Deferred Tax Liabilities	0.03	0.01	0.05	-	0.01	-
Total Liabilities	404.76	334.1	298.18	529.56	205.02	197.74

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	305.72	305.72	276.01	193.67	166.34	113.46
Additional Paid-In Capital	313.79	313.75	296.21	36.88	36.85	12.31
Retained Earnings	167.53	238.06	245.56	167.55	63.7	48.85
Treasury Stock	-28.36	-28.36	-	-	-	-
Total Common Equity	819.21	829.16	817.78	398.09	266.89	174.62
Minority Interest	3.08	3.07	3.04	3.29	1.68	3.3
Shareholders' Equity	822.29	832.23	820.82	401.38	268.57	177.91
Total Liabilities & Equity	1,227	1,166	1,119	930.94	473.59	375.65

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	107.4	113.28	158.83	330.27	118.83	144.75
Net Cash (Debt)	266.65	226.1	223.6	-163.18	-43.79	-58.33
Net Cash Growth	-11.25%	1.12%	-	-	-	-
Net Cash Per Share	7.26	6.15	6.38	-4.80	-1.40	-2.01
Filing Date Shares Outstanding	36.29	36.33	36.46	33.26	32.85	27.89
Total Common Shares Outstanding	36.29	36.33	36.46	33.26	32.85	27.89
Working Capital	316.67	345.06	342.42	115.57	61.94	67.83
Book Value Per Share	22.58	22.83	22.43	11.97	8.12	6.26
Tangible Book Value	815.62	825.22	811.82	394.84	265.42	173.42
Tangible Book Value Per Share	22.48	22.72	22.27	11.87	8.08	6.22
Land	-	214.44	214.44	214.44	87.04	87.04
Buildings	-	264.95	260.13	241.98	-	6.2
Machinery	-	159.98	149.35	113.95	87.08	83.76
Construction In Progress	-	-	-	9.78	125.77	61.92
Leasehold Improvements	-	5.5	7.43	7.4	7.36	1.02

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 20, 2026

Data Sources Report a data error